Stay updated on Imsidolimab for Palmoplantar Pustulosis Clinical Trial

Sign up to get notified when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A minor version update was applied (from v3.3.1 to v3.3.2); no user-visible content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:01:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision update from v3.2.0 to v3.3.1 with no changes to trial details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:36:01.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Notice about potential government funding delays and NIH operating status has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T06:54:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The screenshots show only minor visual or layout adjustments (such as header styling) with no changes to core study data like PPP criteria, primary/secondary outcomes, enrollment numbers, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:16:16.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T10:15:27.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Core content refocused to the term 'Palmoplantar pustulosis' with an updated revision: v3.1.0, and several older or broader drug-safety topics removed (e.g., 'Pustulosis palmaris et plantaris', 'Counterfeit Drugs', 'Substandard Drugs', 'Pharmaceutical Preparations'), plus the old revision tag v3.0.2 deleted.
    Difference
    0.7%
    Check dated 2025-09-28T03:18:19.000Z thumbnail image

Stay in the know with updates to Imsidolimab for Palmoplantar Pustulosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.